📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study. (2021)

First Author: RA-MAP Consortium

Attributed to: Maximising Therapeutic Utility for Rheumatoid Arthritis using genetic and genomic tissue responses to stratify medicines. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1759720x211043977

PubMed Identifier: 34707695

Publication URI: http://europepmc.org/abstract/MED/34707695

Type: Journal Article/Review

Volume: 13

Parent Publication: Therapeutic advances in musculoskeletal disease

ISSN: 1759-720X